Quest Diagnostics Inc Restricted Cash
Quest Diagnostics Inc (DGX) had Restricted Cash of $0 as of 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2020-02-20
- 2019-12-31: Restricted Cash $0.00.
- 2019-09-30: Restricted Cash $0.00.
- 2019-06-30: Restricted Cash $0.00.
- 2019-03-31: Restricted Cash $0.00.
| Period end | Restricted Cash |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-20 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-23 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 |
| 2019-03-31 | $0.00 10-Q · filed 2019-04-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-20 |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-23 |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-24 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-20 |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-24 |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-25 |
| 2017-03-31 | $0.00 10-Q · filed 2018-04-20 |
| 2016-12-31 | $25.00M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |